FeaturedNeurologyNeuroscience·August 4, 2022·4 min readNew Therapeutic Drug for Alzheimer’s Disease Without Inflammatory Side EffectsA newly developed novel fusion protein drug efficiently eliminates amyloid beta via an entirely different mechanism than amyloid-beta antibody-based immunotherapy.Read More
FeaturedNeurologyNeuroscience·August 1, 2022·6 min readIs Everything We Think We Know About Alzheimer’s Wrong?Recent scandals in Alzheimer's research and problems with medications designed to help those with Alzheimer's but failing to deliver sufficient results have researchers questioning the overwhelming focus on amyloid-beta in Alzheimer's research.Read More
FeaturedNeurologyNeuroscience·June 7, 2021·3 min readFDA Grants Accelerated Approval for Alzheimer’s Drug – AduhelmAduhelm, a new drug that appears to reduce amyloid plaques in the brain, is the first new Alzheimer's disease medication to be approved since 2003, and is the first drug that targets the fundamental pathology of the disease.Read More